Your Source for Venture Capital and Private Equity Financings

Benchling Raises $200M Series E Round

SAN FRANCISCO, CA, Benchling, the leading life sciences R&D cloud, has raised $200 million in Series E funding.
The round was led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital and Elad Gil. Existing investors participated, including Thrive Capital, Benchmark, Menlo Ventures, Alkeon Capital, ICONIQ, Lux Capital, Spark Capital and Lead Edge Capital. The company will use the funding to aggressively invest in product development and global expansion to support enterprise customers.

Benchling is the first R&D cloud platform powering the life science industry and helping the next generation of scientists make breakthrough discoveries and bring them to market faster than ever before. Multinational pharmaceutical corporations, high-growth biotechnology companies and major research institutions alike trust Benchling to speed collaboration and convert the complexity of life sciences into world-changing results. For more, please visit
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors

Featured Reading